Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−9 JPY
−780.00 M JPY
135.51 M JPY
64.64 M
About NANO MRNA CO LTD
Sector
CEO
Shiro Akinaga
Headquarters
Tokyo
Website
Founded
1996
ISIN
JP3651120002
FIGI
BBG000V9N9X4
NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4571 is 164 JPY — it has decreased by −1.20% in the past 24 hours. Watch NANO MRNA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NANO MRNA CO LTD stocks are traded under the ticker 4571.
4571 stock has fallen by −1.80% compared to the previous week, the month change is a −11.83% fall, over the last year NANO MRNA CO LTD has showed a −13.23% decrease.
4571 reached its all-time high on May 8, 2013 with the price of 5,630 JPY, and its all-time low was 37 JPY and was reached on Oct 10, 2008. View more price dynamics on 4571 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4571 stock is 2.44% volatile and has beta coefficient of 0.62. Track NANO MRNA CO LTD stock price on the chart and check out the list of the most volatile stocks — is NANO MRNA CO LTD there?
Today NANO MRNA CO LTD has the market capitalization of 11.58 B, it has increased by 3.05% over the last week.
Yes, you can track NANO MRNA CO LTD financials in yearly and quarterly reports right on TradingView.
NANO MRNA CO LTD is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4571 net income for the last quarter is −156.08 M JPY, while the quarter before that showed −42.55 M JPY of net income which accounts for −266.85% change. Track more NANO MRNA CO LTD financial stats to get the full picture.
No, 4571 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 18.00 employees. See our rating of the largest employees — is NANO MRNA CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANO MRNA CO LTD EBITDA is −748.51 M JPY, and current EBITDA margin is −637.09%. See more stats in NANO MRNA CO LTD financial statements.
Like other stocks, 4571 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANO MRNA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANO MRNA CO LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANO MRNA CO LTD stock shows the sell signal. See more of NANO MRNA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.